Neoadjuvant Targeted Therapy for Resectable ALK-fusion Locally Advanced Non-small Cell Lung Cancer

被引:0
|
作者
Zhao, D. [1 ]
Wu, N. [1 ]
机构
[1] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China
关键词
Neoadjuvant; Targeted therapy; ALK-fusion;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.01-02
引用
收藏
页码:S295 / S296
页数:2
相关论文
共 50 条
  • [1] Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small Cell Lung Cancer with ALK Rearrangement
    Zhang, Chao
    Li, Shao-lei
    Nie, Qiang
    Dong, Song
    Shao, Yang
    Yang, Xue-ning
    Wu, Yi-long
    Yang, Yue
    Zhong, Wen-zhao
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (04) : 726 - 731
  • [2] Comprehensive study of neoadjuvant targeted therapy for resectable non-small cell lung cancer
    Bao, Yi
    Gu, Chang
    Xie, Huikang
    Zhao, Shengnan
    Xie, Dong
    Chen, Chang
    Jiang, Gening
    Dai, Chenyang
    Zhu, Yuming
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (06)
  • [3] Neoadjuvant therapy for resectable non-small cell lung cancer
    Welcker, Katrin
    Jonigk, Danny
    Kropf-Sanchen, Cornelia
    Tufman, Amanda
    Draube, Andreas
    Stenzinger, Albrecht
    Zaatar, Mohamed
    Thomas, Michael
    PNEUMOLOGIE, 2025, 79 (01): : 16 - 24
  • [4] USEFULNESS OF IHC FOR DETECTION OF THE ALK-FUSION GENE IN NON-SMALL CELL LUNG CANCER
    Sugiyama, Eri
    Goto, Koichi
    Ishii, Genichiro
    Umemura, Shigeki
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Niho, Seiji
    Ohmatsu, Hironobu
    Ohe, Yuichiro
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1172 - S1173
  • [5] Intensity of neoadjuvant therapy in resectable non-small cell lung cancer
    Green, MR
    Barkley, JE
    LUNG CANCER, 1997, 17 : S111 - S119
  • [6] Induction or neoadjuvant therapy in resectable non-small cell lung cancer
    Langer, CJ
    SEMINARS IN ONCOLOGY, 1999, 26 (05) : 34 - 39
  • [7] Neoadjuvant therapy and surgical resection for locally advanced non-small cell lung cancer
    Meko, J
    Rusch, VW
    SEMINARS IN RADIATION ONCOLOGY, 2000, 10 (04) : 324 - 332
  • [8] Neoadjuvant therapy for locally advanced non-small cell lung cancer: TKIs or immunotherapy?
    Zhang, Zhenyang
    Lin, Jiangbo
    Kang, Mingqiang
    JOURNAL OF THORACIC DISEASE, 2020, 12 (03) : 1151 - 1153
  • [9] Neoadjuvant Ceritinib for Locally Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: SAKULA Trial
    Zenke, Y.
    Yoh, K.
    Sakakibara-Konishi, J.
    Daga, H.
    Hosomi, Y.
    Nogami, N.
    Okamoto, I.
    Matsumoto, S.
    Kuroda, S.
    Wakabayashi, M.
    Nomura, S.
    Ishii, G.
    Sato, A.
    Tsuboi, M.
    Goto, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S626 - S627
  • [10] Crizotinib: A targeted therapy in advanced ALK-positive non-small cell lung cancer
    Toffart, A. -C.
    Sakhri, L.
    Moro-Sibilot, D.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2013, 69 (02) : 111 - 116